Clinical Trials
All Clinical Trials - Page 44 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT01140893Phase 2/Phase 3Unknown
Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes
Exenatide
- NCT01270191Phase 4Unknown
The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
Exenatide
- NCT01242748Phase 3Terminated
A Degarelix Trial in Patients With Prostate Cancer
Gonadorelin
- NCT01299012N/ACompleted
Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus
Liraglutide
- NCT01237197Phase 2Completed
Exenatide in Extreme Pediatric Obesity
Exenatide
- NCT01364584N/ACompleted
Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
Exenatide
- NCT01204840Phase 2Completed
Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)
Gonadorelin
- NCT01888744Phase 4Completed
Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist
Gonadorelin
- NCT01226966N/ACompleted
Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes
Liraglutide
- NCT01215968Phase 1Completed
A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes Mellitus
Dulaglutide
- NCT01179048Phase 3Completed
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
Liraglutide
- NCT04943159Phase 2Completed
Afamelanotide in Patients Suffering With Acne Vulgaris
Afamelanotide
- NCT01175473Phase 2Completed
Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes
Liraglutide
- NCT01237119Phase 2Completed
Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis
Liraglutide
- NCT01147627N/ACompleted
Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
Exenatide
- NCT01181986Phase 4Completed
The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes
Exenatide
- NCT01161563Phase 4Completed
Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration
Gonadorelin
- NCT01117350Phase 4Completed
Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure
Liraglutide
- NCT01174810Phase 2Unknown
Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
Exenatide
- NCT01588418Phase 4Completed
Acute Effect of Exenatide on Brain Glucose Metabolism
Exenatide
- NCT01156779Phase 1Completed
Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects
Exenatide
- NCT01144338Phase 3Completed
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide
- NCT01136798N/ACompleted
Impact of Exenatide on Sleep in Type 2 Diabetes
Exenatide
- NCT01165619N/ATerminated
Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders
Gonadorelin
- NCT01457703N/ACompleted
Reproductive Hormonal Alterations in Obesity
Gonadorelin
- NCT01149421Phase 2Completed
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
Dulaglutide
- NCT04704713Phase 3Completed
Afamelanotide in Patients Suffering From Polymorphic Light Eruption (PLE)
Afamelanotide
- NCT01115920Phase 1Completed
Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of Intravenous (IV) Infusion of MTP-131 (Bendavia™) in Healthy Adults
Elamipretide
- NCT01128894Phase 3Completed
A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.
Liraglutide
- NCT01126580Phase 3Completed
A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)
Dulaglutide
- NCT01104701Phase 2Completed
A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension
Exenatide
- NCT01097044Phase 2Completed
Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)
Afamelanotide
- NCT01208012Phase 4Completed
Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus
Liraglutide
- NCT01089569N/ACompleted
Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine
Exenatide
- NCT01951651Phase 4Completed
Effect of Exenatide on Liver and Heart Fat and Inflammation
Exenatide
- NCT01060059N/ACompleted
Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes
Exenatide
- NCT01023061Phase 2Completed
Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer
Gonadorelin
- NCT01092494N/AUnknown
Postoperative Cyclic Oral Contraceptive Use for the Prevention of Endometrioma Recurrence
Gonadorelin
- NCT01073865Phase 3Completed
Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer
Gonadorelin
- NCT01075282Phase 3Completed
A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)
Dulaglutide
- NCT01064687Phase 3Completed
A Study in Participants With Type 2 Diabetes Mellitus
Dulaglutide
- NCT01093729Phase 1Completed
A Study of HM11260C in Healthy Male Subject
Exenatide
- NCT00747968Phase 2/Phase 3Completed
The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET
Exenatide
- NCT01029886Phase 3Completed
Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes
Liraglutide
- NCT01056549N/ACompleted
Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans
Exenatide
- NCT01061775Phase 1/Phase 2Completed
Effects of Exenatide on Hypothalamic Obesity
Exenatide
- NCT01278290Phase 3Completed
Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls
Gonadorelin
- NCT01784965Phase 3Completed
Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.
Liraglutide
- NCT01031966Phase 2Completed
A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine
Thymosin-Alpha-1
- NCT00843570Phase 4Completed
Natural Versus HRT Cycles in Frozen Embryo Replacement Treatment
Gonadorelin